Goldspan Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: GLP-1 protocols inside a wider peptide and longevity menu
Goldspan Health scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
Price checked on Goldspan Health’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Goldspan Health is a longevity-focused telehealth platform selling physician-prescribed GLP-1 and peptide protocols across eleven categories, dispensed by licensed 503A and 503B pharmacies. Weight-loss protocols come as semaglutide or tirzepatide injections paired with B12 or glycine, ordered through a third-party storefront.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Goldspan Health
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
from $229/4 wks (billed per 4 weeks) · no insurance needed
Goldspan Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $229/4 wks (billed per 4 weeks)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Goldspan Health
Each dimension is scored algorithmically from Goldspan Health’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.7/10At $229/mo (per 4 weeks), Goldspan Health runs about 28% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.2/10Goldspan Health offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.2/10Online intake and platform experience (consult included in the price); 3 platform features disclosed.
Trust & Safety15%
7.4/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.2/10Goldspan Health's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
6.0/10Goldspan Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Goldspan Health review
Last checked November 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $229–$299/mo across 2 dose/plan tiers (checked November 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Goldspan Health
We walked Goldspan Health’s public signup flow in August 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Browse the eleven protocol categories or take the on-site quiz.
- 2Open the Weight Loss category and choose semaglutide or tirzepatide.
- 3Pick a variant: injection with B12, or with glycine.
- 4Follow the product link out to the third-party storefront, where the price is shown.
- 5Complete the intake there; an independent medical group reviews and prescribes if appropriate.
- No price is published anywhere on Goldspan Health's website, including the homepage, the category page and the site's JavaScript bundle.
- Prices appear only after clicking through to the third-party storefront: $229.00/month semaglutide, $299.00/month tirzepatide.
- That storefront states the real cadence: 'a new monthly supply arrives automatically every 4 weeks', which is 13 charges a year.
- The storefront product page shows the price before any account or payment is required.
GLP-1 medications Goldspan Health offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Advertised per month, but a new supply ships and is charged every 4 weeks. That is 13 charges a year, about $2,977/yr rather than $2,748. The price appears only on the third-party storefront the product links to, not on Goldspan Health's website.
Same 4-week cycle, so 13 charges a year come to about $3,887/yr rather than $3,588. The price is published only on the third-party storefront.
Ready to get started?
Plans and promotions change often, so check Goldspan Health's current pricing and active discounts before you decide.
What we like
- Names its pharmacy class outright: 'dispensed by a pharmacy licensed under U.S. FDA §503A or §503B'
- Both GLP-1 molecules offered, each pairable with B12 or glycine, plus microdose and sublingual variants
- Subscription can be paused, delayed or canceled at any time
- Free discreet shipping on every delivery
Watch-outs
- Prices appear nowhere on Goldspan Health's website: you must click through to a third-party storefront to see any figure
- Billed every 4 weeks while advertised as monthly, which is 13 charges a year rather than 12
- Among the more expensive compounded GLP-1s we track at $229 and $299
- The homepage claims 'In 50 states' but the terms say some therapies are unavailable in certain states
Goldspan Health in one line: a longevity menu where the price lives on somebody else's site
Goldspan Health sells physician-prescribed semaglutide and tirzepatide inside a wider catalog of peptide protocols spanning eleven categories, all dispensed by licensed 503A and 503B pharmacies. The clinical framing is careful and the pharmacy disclosure is better than most. Two things count against it: you cannot find out what anything costs without leaving the site, and when you do find out, the billing cycle is not the one advertised.
Finding the price is the first obstacle
Nothing on Goldspan Health's website carries a price, including the homepage, the weight-loss category page and the product cards. Even the site's own product catalog, down to the code behind it, holds no price fields at all. Every product instead links out to a third-party storefront, and only there do the numbers appear: $229 a month (per 4 weeks) for semaglutide and $299 for tirzepatide, both for the injection paired with B12.
That is a meaningful transparency gap. A reader comparing providers has to click through to an unfamiliar domain per product just to learn the rate, and there is no pricing page to bookmark or compare. Against a category median of about $179 a month, both figures also sit at the expensive end. Goldspan is not competing on price, and the site's own framing doesn't pretend otherwise.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
The month is not a month
The storefront advertises both products with a "/month" suffix. It then explains, further down the same page, that after your first delivery a new supply arrives automatically every 4 weeks. Those are not the same thing. A four-week cycle produces thirteen charges in a year, not twelve, so the actual annual cost is one full extra payment above what multiplying the advertised monthly price gives you.
This is a common trap in compounded telehealth, and few sellers state it as plainly as Goldspan does. The price is still displayed as monthly, though, and most readers will never scroll to the sentence that corrects it. Budget for thirteen payments a year on either molecule.
- Semaglutide: $229 (per 4 weeks), injection with B12 or glycine
- Tirzepatide: $299, same variant structure
- Real cadence: reships every 4 weeks, which means 13 charges a year, not 12
- Where the price lives: a third-party storefront, not Goldspan Health's own site
What Goldspan does better than most
The pharmacy disclosure is strong. Goldspan's terms state that all therapies are dispensed by a pharmacy licensed under FDA §503A or §503B, and that the platform connects customers with an independent medical group and those pharmacies. Naming the regulatory class outright is more than most compounded sellers manage, even if no individual facility is named. For readers who want a named facility and prices on the provider's own site, AVARA Rx names its pharmacy and clinical network and posts its starting prices directly, though it doesn't itemize them by dose.
The catalog is also unusually thoughtful. Each GLP-1 comes paired with either B12 or glycine (the site frames these as energy versus muscle maintenance), and a separate inflammation category carries microdose semaglutide and tirzepatide protocols, including a sublingual option. For a patient interested in low-dose or non-injectable approaches, that widens the choice. Subscriptions can be paused, delayed or canceled at any time, and shipping is free.
Who should choose Goldspan, and who should walk
Choose it if you want a GLP-1 as part of a broader peptide and longevity protocol rather than as a standalone weight-loss purchase, and if the 503A/503B framing and the microdose options matter to you. The clinical presentation is serious and the flexibility on variants and dosing is better than the category norm.
Skip it if price transparency matters, or if you are cost-sensitive. Having to leave the site to learn the rate is a poor experience, thirteen annual charges makes an already-expensive product more so, and the homepage's "In 50 states" claim sits against terms warning that some therapies are unavailable in certain states. If care inside a primary care practice matters more to you and you live in Georgia or Texas, Ascend Medical runs its weight program next to primary, mental health and diabetes care, though it doesn't say whether its GLP-1s are brand or compounded.
Bottom line
Goldspan Health is a credible longevity platform with better pharmacy disclosure than most and an unusually broad protocol catalog, and it has no FDA warning letters on file. But it publishes no prices on its own site, sends you to a third party to find them, and bills every four weeks under a monthly label. If you want what Goldspan sells, go in knowing you will pay thirteen times a year, and confirm your state before you start.
The Bottom Line
Goldspan Health scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Goldspan Health?
From $229/4 wks (billed per 4 weeks). See current pricing and start your free consultation.
Goldspan Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Goldspan Health vs…
Goldspan Health scores7.1/10
Side-by-side pricing, medications and scores. Pick a matchup.
Goldspan Health vs Amazon One Medical
Amazon One Medical scores 8.5/10

Goldspan Health vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Goldspan Health review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Goldspan Health's current pricing
Plans from $229/4 wks (billed per 4 weeks). Start your free consultation to check eligibility and today's price.